FDA Investigator: Jacek Cieslak
- Jacek Cieslak first started conducting FDA inspections in 2018, with the last inspection in 2023. Over that time, Jacek Cieslak has conducted 10 inspections at 10 companies across 10 sites.
Get Jacek Cieslak's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Samsung Biologics Co., Ltd., Yeonsu | 2023
Out-of-stock
Jacek Cieslak
Human Drugs Form 483
FDA 483 Alexion Pharma International Operations Unlimited Co., Dublin 15 | 2023
Out-of-stock
Jacek Cieslak
Human Drugs Form 483
FDA 483 SEAGEN INC., Bothell | 2022
Out-of-stock
Jacek Cieslak
Human Drug Form 483
FDA 483 Polpharma Biologics S.A, Gdansk | 2022
Out-of-stock
Jacek Cieslak
Human Drug Form 483
FDA 483 Kyowa Hakko Kirin Co., Ltd., Takasaki | 2021
Out-of-stock
Jacek Cieslak
Human Drug Form 483
FDA 483 Chugai Pharma Manufacturing Co. Ltd. (CPMC), Kita | 2021
Out-of-stock
Jacek Cieslak
Human Drug Form 483
FDA 483 FujiFilm Diosynth Biotechnologies U.S.A., Inc., Research Triangle Park | 2021
Out-of-stock
Jacek Cieslak
Human Drug Form 483
Co-Investigators (15)
- Dogbeda F. Mackenzie, FDA Investigator
- Wayne E. Seifert, FDA Investigator
- Jeffrey P. Raimondi, FDA Investigator
- Hyung-Yul Lee, FDA Investigator
- Zhong Li, FDA Investigator
- Christopher R. Czajka, FDA Investigator
- Wendy G. Tan, FDA Investigator
- Michael Shanks, FDA Investigator
- Matthew B. Casale, FDA Investigator
- Michael A. Charles, FDA Investigator
- Seneca D. Toms, FDA Investigator
- Yun Wu, FDA Investigator
- Zhihao Pete Qiu, FDA Investigator
- Richard Ledwidge, FDA Investigator
- Ashar P. Parikh, FDA Investigator